Ensuring Access to Immunoglobulin Therapies for People with Primary Immunodeficiency: A Need to Improve Individuals' Quality of Life and the Sustainability of Health-care Systems

Front Immunol. 2017 Sep 19:8:1165. doi: 10.3389/fimmu.2017.01165. eCollection 2017.

Ahmed Aziz Bousfiha^{1

2

3

4}, Carla Duff^{1

2

3

4}, Elena Hsieh^{3

4}

¹ Clinical Immunology Unit, Casablanca Children Hospital CHU Averroes and Medical School King Hassan II University, Casablanca, Morocco.
² Division of Allergy and Immunology, Department of Paediatrics, University of South Florida, Tampa, FL, United States.
³ Division of Allergy and Immunology, Department of Paediatrics, School of Medicine, University of Colorado, Children's Hospital Colorado, Aurora, CO, United States.
⁴ Department of Immunology and Microbiology, School of Medicine, University of Colorado, Children's Hospital Colorado, Aurora, CO, United States.

No abstract available

Keywords: access to care; immunoglobulin replacement therapy; primary immunodeficiency diseases; subcutaneous immunoglobulins.